SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:lup.lub.lu.se:042d7056-e0d2-4be6-87a2-2b814cb291f5"
 

Search: onr:"swepub:oai:lup.lub.lu.se:042d7056-e0d2-4be6-87a2-2b814cb291f5" > Evaluation of the c...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Johansson, Peter A.QIMR Berghofer Medical Research Institute (author)

Evaluation of the contribution of germline variants in BRCA1 and BRCA2 to uveal and cutaneous melanoma

  • Article/chapterEnglish2019

Publisher, publication year, extent ...

  • 2019
  • 8 s.

Numbers

  • LIBRIS-ID:oai:lup.lub.lu.se:042d7056-e0d2-4be6-87a2-2b814cb291f5
  • https://lup.lub.lu.se/record/042d7056-e0d2-4be6-87a2-2b814cb291f5URI
  • https://doi.org/10.1097/CMR.0000000000000613DOI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:142831844URI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:art swepub-publicationtype
  • Subject category:ref swepub-contenttype

Notes

  • Germline mutations of BRCA1 and BRCA2 predispose individuals to a high risk of breast and ovarian cancer, and elevated risk of other cancers, including those of the pancreas and prostate. BRCA2 mutation carriers may have increased risk of uveal melanoma (UM) and cutaneous melanoma (CM), but associations with these cancers in BRCA1 mutation carriers have been mixed. Here, we further assessed whether UM and CM are associated with BRCA1 or BRCA2 by assessing the presence, segregation and reported/predicted pathogenicity of rare germline mutations (variant allele frequency < 0.01) in families with multiple members affected by these cancers. Whole-genome or exome sequencing was performed on 160 CM and/or UM families from Australia, the Netherlands, Denmark and Sweden. Between one and five cases were sequenced from each family, totalling 307 individuals. Sanger sequencing was performed to validate BRCA1 and BRCA2 germline variants and to assess carrier status in other available family members. A nonsense and a frameshift mutation were identified in BRCA1, both resulting in premature truncation of the protein (the first at p.Q516 and the second at codon 91, after the introduction of seven amino acids due to a frameshift deletion). These variants co-segregated with CM in individuals who consented for testing and were present in individuals with pancreatic, prostate and breast cancer in the respective families. In addition, 33 rare missense mutations (variant allele frequency ranging from 0.00782 to 0.000001 in the aggregated ExAC data) were identified in 34 families. Examining the previously reported evidence of functional consequence of these variants revealed all had been classified as either benign or of unknown consequence. Seeking further evidence of an association between BRCA1 variants and melanoma, we examined two whole-genome/exome sequenced collections of sporadic CM patients (total N = 763). We identified one individual with a deleterious BRCA1 variant, however, this allele was lost (with the wild-type allele remaining) in the corresponding CM, indicating that defective BRCA1 was not a driver of tumorigenesis in this instance. Although this is the first time that deleterious BRCA1 mutations have been described in high-density CM families, we conclude that there is an insufficient burden of evidence to state that the increased familial CM or UM susceptibility is because of these variants. In addition, in conjunction with other studies, we conclude that the previously described association between BRCA2 mutations and UM susceptibility represents a rare source of increased risk.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Nathan, VaishnaviQIMR Berghofer Medical Research Institute (author)
  • Bourke, Lauren M.QIMR Berghofer Medical Research Institute (author)
  • Palmer, Jane M.QIMR Berghofer Medical Research Institute (author)
  • Zhang, TongwuNational Cancer Institute, USA (author)
  • Symmons, JudithQIMR Berghofer Medical Research Institute (author)
  • Howlie, Madeleine (author)
  • Patch, Ann MarieQIMR Berghofer Medical Research Institute (author)
  • Read, JazlynQIMR Berghofer Medical Research Institute (author)
  • Holland, Elizabeth A.University of Sydney (author)
  • Schmid, HelenUniversity of Sydney (author)
  • Warrier, SunilTerrace Eye Centre, Brisbane (author)
  • Glasson, WilliamTerrace Eye Centre, Brisbane (author)
  • Höiom, VeronicaKarolinska Institutet,Karolinska Institute (author)
  • Wadt, KarinCopenhagen University Hospital (author)
  • Jönsson, GöranLund University,Lunds universitet,Melanoma Genomics,Forskargrupper vid Lunds universitet,Lund University Research Groups,Skåne University Hospital(Swepub:lu)onk-gjo (author)
  • Olsson, HåkanLund University,Lunds universitet,Lunds Melanomstudiegrupp,Forskargrupper vid Lunds universitet,Lund Melanoma Study Group,Lund University Research Groups,Skåne University Hospital(Swepub:lu)onk-hol (author)
  • Ingvar, ChristianLund University,Lunds universitet,Lunds Melanomstudiegrupp,Forskargrupper vid Lunds universitet,Lund Melanoma Study Group,Lund University Research Groups,Skåne University Hospital(Swepub:lu)kir-cin (author)
  • Mann, GrahamUniversity of Sydney (author)
  • Brown, Kevin M.National Cancer Institute, USA (author)
  • Hayward, Nicholas K.QIMR Berghofer Medical Research Institute (author)
  • Pritchard, Antonia L.University of the Highlands and Islands,QIMR Berghofer Medical Research Institute (author)
  • QIMR Berghofer Medical Research InstituteNational Cancer Institute, USA (creator_code:org_t)

Related titles

  • In:Melanoma Research29:5, s. 483-4900960-89311473-5636

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view